MediXall Group Inc. Appoints Ellis A. Ellis to Strategic Advisory Board
March 15, 2019 at 12:30 pm
Share
MediXall Group Inc. announced the expansion of its strategic advisory board with the appointment of clinical pharmacist and scientific liaison Ellis A. Ellis. Dr. Ellis’ distinguished career includes work with the Department Health Services (DHS) Medi-Cal Drug Formulary, compliance consultant, process efficiency expert and published author of original research related to drug to drug interactions. As an Advisor, Dr. Ellis will provide guidance and support on strategic initiatives as the company accelerates business growth, expands its services, and strives to increase market share. As a member of the board, Dr. Ellis will work closely with the MediXall leadership team to consult on business strategy and sales, marketing, and product plans, as well as provide guidance on the implementation of the MediXallRx Discount program.
MediXall Group, Inc. is a technology company. The Company is engaged in delivering products and services to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors. With Health Karma, it has created a membership model that provides consumers with convenience and access to whenever and wherever, while driving down overall healthcare costs. It provides its members access to licensed healthcare providers across a spectrum of care through copay virtual primary, urgent, and behavioral care, as well as significant discounts to prescriptions, dental care, eye care, hearing and medical equipment. For employers, Its Health Karma membership offers a comprehensive way for them to offer supplemental health benefits to all of their employees, including part-time and gig workers. The Companyâs subsidiaries include Medixaid, Inc., MediXall.com, Inc. and Health Karma, Inc.
MEDIXALL GROUP, INC. 
